Actively Recruiting
Exploring the Inflammatory Link Between Asthma and Primary Arterial Hypertension in Adults
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-10-30
74
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a low-intervention, prospective study to explore the inflammatory, functional, and clinical differences between patients who have asthma alone and those who have both asthma and primary arterial hypertension. The goal is to improve understanding of asthma and its related health conditions, focusing on how these diseases may interact. This observational research is sponsored by Istituti Clinici Scientifici Maugeri SpA. Participants will not receive experimental treatments but will undergo measurements of inflammatory markers, such as Interleukin 4, 5, and 13, and lung function tests including FEV1. These assessments will occur at the start of the study and again after four years to monitor changes over time. The study includes two groups patients with asthma and patients with both asthma and hypertension. Participants will be involved in clinical evaluations and complete questionnaires measuring asthma control at baseline and after four years. Researchers will track inflammatory and lung function markers to better understand disease progression and interactions. The study spans several years, with primary outcomes measured at two time points, helping to assess long-term changes in health status related to asthma and hypertension.
CONDITIONS
Brief Title
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Research Team
D
Dina Visca, Professor
F
Francesco Ardesi, Medical doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here